Rxi Pharmaceuticals Stock Quote | Stock Price for RXII ... Nov 16, 2018 · RXi Pharmaceuticals to Present New Data from its Immuno-Oncology Program Using sd-rxRNA Therapeutic Compounds Targeting Intracellular Checkpoint Cbl-b in NK Cells at the 16th Annual Discovery on Targe RXi Pharmaceuticals Announces Reverse Stock Split As previously reported, RXi Pharmaceuticals currently has until January 29, 2018 to regain compliance with the Nasdaq Stock Market's minimum bid price requirement, and, to regain compliance, RXi RXi Pharmaceuticals - Stock Price History | PHIO | MacroTrends Mar 14, 2013 · Historical daily share price chart and data for RXi Pharmaceuticals since 2019 adjusted for splits. The latest closing stock price for RXi Pharmaceuticals as of December 27, 2019 is 0.15.. The all-time high RXi Pharmaceuticals stock closing price was 990.99 on March 14, 2013.; The RXi Pharmaceuticals 52-week high stock price is 0.53, which is 253.3% above the current share price. Stock Analysis for RXI Pharmaceuticals Corporation (RXII)
Historical index on US Stock Market : D-"Should I invest in RXi Pharmaceuticals stock?" "Should I trade "RXII" stock today?" According to our live Forecast System, RXi Pharmaceuticals Corporation stock is a bad long-term (1-year) investment*. "RXII" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.
RXi Pharmaceuticals Announces Reverse Stock Split ... Apr 15, 2016 · As previously reported, RXi Pharmaceuticals currently has until May 2, 2016 to regain compliance with the Nasdaq Stock Market's minimum bid price requirement, and, to … RXi Pharmaceuticals - Investor Relations - Phio ... Phio Pharmaceuticals is focused on developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL TM) therapeutic platform.Immunotherapies harness our immune system to restore surveillance of tumors that evade detection – a … Rxi Pharmaceuticals (RXII) stock price today - RXII quote
Oct 10, 2019 · Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
IPO Last Funding Type Post-IPO Equity Number of Employees 11-50 Also Known As RXi Pharmaceuticals. IPO Status Public Stock Symbol NASDAQ:PHIO. Mar 16, 2020 Phio Pharmaceuticals Corp, formerly RXi Pharmaceuticals Corporation, is a biotechnology company. The Company is focused on developing RXII / RXI Pharmaceuticals Corporation Institutional Ownership File Date, Form , Investor, Avg Share Price, Shares, Shares Changed (%), Value ($1000)
Requested symbol wasn't found - Business Finance, Stock ...
Phio Pharmaceuticals Corp. (PHIO) Stock Analysis & News ... Get breaking news and analysis on Phio Pharmaceuticals Corp. (PHIO) stock, price quote and chart, trading and investing tools. The CEO Is Buying RXi Pharmaceuticals Stock.
RXi Pharmaceuticals Announces Reverse Stock Split
Rxi Pharmaceuticals Corp. - Warrants (delisted) (RXIIW) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. RXII Price Target and Analyst Ratings (RXi Pharmaceuticals) Oct 10, 2019 · Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
RXII Split History RXII (RXII) has 2 splits in our RXII split history database. The first split for RXII took place on April 18, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of RXII owned pre-split, the shareholder now owned 1 share. Phio Pharmaceuticals Corp (PHIO) Stock Message Board ...